Elsevier Inc.

SHERPA: Unknown

People

  1. Lewis
    Lewis
  2. Carter
    Carter
  3. Cheung
    Cheung
  4. Eibler
    Eibler
  5. Kesner
    Kesner
  6. Krebs
    Krebs
  7. Lyashchenko
    Lyashchenko
  8. Mcdevitt
    Mcdevitt
  9. Monette
    Monette
  10. O'Donoghue
    O'Donoghue

Groups

  1. Molecular Imaging and Therapy Service (5)
  2. Radiochemistry and Imaging Sciences Service (5)
  3. Radiology, Department of (5)
  4. GSK Faculty (4)
  5. Molecular Pharmacology and Chemistry Program Faculty (3)
  6. Sloan Kettering Institute Faculty (3)
  7. Sloan Kettering Institute Postdocs (3)
  8. Center for Hematologic Malignancies (2)
  9. Center for Pancreatic Cancer Research (2)
  10. Department of Medicine (2)
Search Within
  1. "Meeting abstract"
  2. "Molecular Imaging and Therapy Service"
  3. "Radiochemistry and Imaging Sciences Service"
Formats
  1. Meeting Abstract (5)
Groups
  1. Molecular Imaging and Therapy Service (5)
  2. Radiochemistry and Imaging Sciences Service (5)
  3. Radiology, Department of (5)
  4. GSK Faculty (4)
  5. Molecular Pharmacology and Chemistry Program Faculty (3)
  6. Sloan Kettering Institute Faculty (3)

More Groups

People
  1. Steven Larson (3)
  2. Darren Veach (2)
  3. Jason Lewis (2)
  4. Adam Kesner (1)
  5. Blesida Punzalan (1)
  6. Brian Santich (1)

More People

Years
  1. 2022 (1)
  2. 2019 (1)
  3. 2016 (1)
  4. 2014 (1)
  5. 2006 (1)
Publications
  1. International Journal of Radiation Oncology, Biology, Physics (2)
  2. Biology of Blood and Marrow Transplantation (1)
  3. Clinical Lymphoma, Myeloma and Leukemia (1)
  4. European Journal of Cancer (1)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A radiohapten capture system for CAR T cells that tracks them in vivo and improves efficacy
    Meeting Abstract

    Kurtz, K.; Eibler, L.; Dacek, M.; Carter, L.; Cheal, S.; Veach, D.; Qureshy, S.; Han, J.; Reynaud, E.; Verma, S.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Synthesis, preclinical analysis, and first-in-human phase I imaging of 89Zr-DFO-daratumumab for CD38 targeted imaging of myeloma
    Meeting Abstract

    Ulaner, G.; Sobol, N.; O'Donoghue, J.; Lyashchenko, S.; Lewis, J.; Landgren, C. O.
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Monitoring prostate cancer treatment response to radiation therapy and androgen deprivation with novel radiolabeled and dual-labeled gastrin-releasing peptide receptor (GRPr) antagonists
    Meeting Abstract

    Taunk, N. K.; Zhang, H.; Carlin, S.; Weber, W.
    International Journal of Radiation Oncology, Biology, Physics (2016)

    Fulltext@MSK | Save
  • Molecular imaging for localized prostate cancer: Analysis of 2 prospective phase 0 trials of PSMA targeted immuno-PET and -SPECT, and implications for the radiation oncologist
    Meeting Abstract

    Spratt, D. E.; Fareedy, S.; Lindgren, S.; Robinson, B.; Larson, S. M.; Lewis, J.; Bander, N. H.; Scherr, D. S.; Osborne, J. R.
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save
  • Detection of bcr-abl expression in human cml model using radiolabeled analogue of abl-protein kinase inhibitor and positron-emission tomography (PET)
    Meeting Abstract

    Doubrovin, M.; Beresten, T.; Veach, D.; Namavari, M.; Balatoni, J.; Bornmann, W.; Guelovani, J.; Larson, S.
    Biology of Blood and Marrow Transplantation (2006)

    Fulltext@MSK | Save